Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility
NCT: NCT02234128 · COMPLETED
광고
NCT IDNCT02234128
상태COMPLETED
시작일2015-07-18
완료2019-11-07
SponsorLung Bioengineering Inc. (INDUSTRY)
First posted
Last updated
간략 요약
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.